Drugs and clinical trials in neurodegenerative diseases
Neurodegenerative diseases are disabling conditions continuously increasing due to aging of population. A disease modifying therapy that slows or stops disease progression is therefore a major unmet medical need. Unfortunately, research for effective treatments is hampered by lack of knowledge on th...
Main Authors: | Paolo Stanzione, Domenicantonio Tropepi |
---|---|
Format: | Article |
Language: | English |
Published: |
Istituto Superiore di Sanità
2011-01-01
|
Series: | Annali dell'Istituto Superiore di Sanità |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0021-25712011000100011&lng=en&tlng=en |
Similar Items
-
Need to improve clinical trials in rare neurodegenerative disorders
by: Maria Puopolo, et al.
Published: (2011-01-01) -
Indagini mediche e medici cittadini nella Milano tardomedievale: uno studio dei Libri Mortuorum del 1478
by: Tommaso Bertoglio
Published: (2021-11-01) -
Integrating gender medicine into the workplace health and safety policy in the scientific research institutions: a mandatory task
by: Anna Maria Giammarioli, et al.
Published: (2012-01-01) -
Development and validation of predictive MoSaiCo (Modello Statistico Combinato) on emergency admissions: can it also identify patients at high risk of frailty?
by: Pasquale Falasca, et al.
Published: (2011-01-01) -
Analisi delle denominazioni di malattie in lingua italiana, polacca e inglese in chiave contrastiva svolta sulla base di alcune entità nosologiche tratte dalla Classificazione ICD-10 dell’Organizzazione Mondiale della Sanità
by: Łukasz Jan Berezowski, et al.
Published: (2022-10-01)